Mortgage Blog Ocugen obtains exclusive license for nasal Covid-19 vaccine to complement Covaxin firststargroup September 29, 2022 "We now have another weapon in our arsenal," said Dr. Shankar Musunuri, Ocugen's CEO.
"We now have another weapon in our arsenal," said Dr. Shankar Musunuri, Ocugen's CEO.
